{
    "nct_id": "NCT06597799",
    "official_title": "Phase 1, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose, and Food-Effect Study to Assess Safety, Tolerability, PK and PD of MRT-6160 in Healthy Subjects",
    "inclusion_criteria": "* Healthy, adult, male or females 19-65 years of age\n* Non smoker who has not used nicotine and tobacco containing products for at least 3 months prior to start of study\n* Able to swallow oral medications\n* Understands the study procedures in the informed consent form (ICF) and be willing and able to comply with the protocol\nHealthy volunteers allowed\nMust have minimum age of 19 Years\nMust have maximum age of 65 Years",
    "exclusion_criteria": "* History or presence of clinically significant medical or psychiatric condition or disease that will interfere with adherence to study protocol\n* Underwent surgical intervention or an operation within 4 weeks prior to start of study\n* Has active TB, latent TB, a history of TB, or had close contact with a person with active TB within 8 weeks prior to the first dosing\n* Female subject with a positive pregnancy test or who is lactating\n* Positive urine drug or alcohol screen results\n* Positive COVID-19 results indicating recent or current COVID-19\n* Positive results for human immunodeficiency virus (HIV), hepatitis B or hepatitis C virus or history of resolved hepatitis\n* Participation in another clinical study within 30 days or within 5 half-lives (if known) prior to start of study",
    "miscellaneous_criteria": ""
}